Thursday, December 13, 2012

Dr Rafael Manon Is A Well-Known Expert Oncologist


At only 39 years old, Dr Rafael Manon has quickly become one of the United States’ leading experts on radiation oncology and technological advances in cancer treatments. Rafael Manon received his undergraduate degree from Florida State University, where he graduated summa cum laude from the College of Arts and Sciences. Trained in internal medicine and radiation oncology at the University of Florida and the University of Wisconsin Madison, Rafael Manon received his medical degree in 2000 and since then, has become a well known and widely published physician and researcher at the top of the clinical oncology field.

Working out of the MD Anderson Cancer Center in Orlando, FL, Dr Rafael Manon has become the director of research in the radiation oncology department, and has spearheaded a number of research projects on the use of imaging in reducing healthy tissue damage in radiation-based cancer treatments, through techniques like helical topotherapy, which he helped develop as a resident in Wisconsin. Dr Rafael Manon has won awards such as the Office of Naval Research’s Outstanding Achievement in Science, Engineering, and Mathematics Award and Orlando Health’s Exemplary Physician Colleague Award.

Dr Rafael Manon is a member of a number of organizations, such as the American Society of Clinical Oncology and the American Society of Therapeutic Radiology and Oncology. In addition, Rafael Manon is a faculty member of the University of Texas MD Anderson Cancer Center, Florida State University, and the University of Central Florida, and acted as an instructor in radiological therapies in his final year of residency at the University of Wisconsin. Dr Rafael Manon’s work has been published in a number of peer-reviewed journals, and he consistently breaks new ground in cutting edge studies of technologically based cancer treatments, while simultaneously treating patients with multiple cancer types with astounding success rates.

Sunday, November 18, 2012

Dr Rafael Manon One of Many Developing Cancer Treatments Through Technology


The field of cancer treatment is currently being revolutionized by the development of new and exciting technological methods of fighting tumors and minimizing the negative effects of radiation therapies. Since the late 1800s, doctors have been using radiation to treat cancer, ever since the discovery that X-rays could remove damaging tissue and stop or slow the growth of tumors. However, even with the use of sophisticated methods of delivering X-rays, gamma rays, or other kinds of radiation, patients still stuffer significant side effects, as radiation therapies have often lacked the precision to target tumors or other damaging tissues without affecting surrounding healthy organs.

Today, however, many researchers on the cutting edge of science are developing new methods of improving cancer treatments to make radiation therapies safer, less invasive, and less disruptive to a patient’s quality of life. One of the ways that this is being done is through improving imaging techniques to precisely locate the margins of tumors and aim radiation beams at them in a way that allows treatment to be more accurate and precise, and have less of an effect on surrounding tissues. Rafael Manon, a radiation oncologist at the MD Anderson Cancer Center in Orlando, FL, is one of the leading researchers in this field of oncological imaging, and has recently been exploring and publishing adaptive radiotherapy, which promises to reduce the incidence of side effects and allow for greater precision in treating head, neck, lung, and gynecologic cancers.

Another recent advance in cancer treatment is the development of proton treatment centers, one of which will soon be installed at Rafael Manon’s home base, the MD Anderson Cacner Center. In proton therapy, particle accelerators create a beam of protons that can destroy tumors effectively with minimal scattering of radiation energy, meaning that tissues surrounding tumors receive far lower doses of radiation than the targeted tumors do. As a result of its precision, tumors that are extremely close to vital organs can be attacked without the same harmful effect on healthy tissue that traditional radiation therapy would have.